Pharmabiz

GRIN Therapeutics' initiates pivotal phase 3 Beeline study of radiprodil for GRIN-related neurodevelopmental disorder

GRIN Therapeutics' initiates pivotal phase 3 Beeline study of radiprodil for GRIN-related neurodevelopmental disorder: New York Tuesday, May 5, 2026, 17:00 Hrs [IST] GRIN Therapeu ...
Pharmabiz

ADMA Biologics receives US FDA approval to expand the label for Asceniv to include paediatric immune compromised patients two years of age and older

ADMA Biologics receives US FDA approval to expand the label for Asceniv to include paediatric immune compromised patients two years of age and older: Ramsey, New Jersey Tuesday, M ...
Pharmabiz

MrMed expands infrastructure with a 850 sq ft facility, signalling next phase of growth in storage and distribution

MrMed expands infrastructure with a 850 sq ft facility, signalling next phase of growth in storage and distribution: Our Bureau, Bengaluru Tuesday, May 5, 2026, 15:30 Hrs [IST] Mr ...
Pharmabiz

Ascidian completes dose escalation portion of phase 1/2 STELLAR trial of ACDN-01 for Stargardt disease

Ascidian Therapeutics, a biotechnology company seeking to treat human diseases by rewriting RNA, announced the completion of the adult dose escalation portion of the STELLAR phase 1/2 clinical trial ...
Pharmabiz

C-CAMP launches the 9th Edition National Bio Entrepreneurship Competition 2026

C-CAMP launches the 9th Edition National Bio Entrepreneurship Competition 2026: Our Bureau, Bengaluru Tuesday, May 5, 2026, ...
Pharmabiz

QR678 notes 30% hair regrowth without drugs as scientists discover reactivation of hair stem cells

QR678 notes 30% hair regrowth without drugs as scientists discover reactivation of hair stem cells: Our Bureau, Bengaluru Tuesday, May 5, 2026, 14:45 Hrs [IST] QR678, a clinically ...
Pharmabiz

Amgen to invest an additional $300 million in its US manufacturing network to advance US-based production capacity

Amgen to invest an additional $300 million in its US manufacturing network to advance US-based production capacity: Thousand Oaks, California Tuesday, May 5, 2026, 14:00 Hrs [IST] ...
Pharmabiz

HOSMAC spearheads north Maharashtra’s project management for Tapanbhai Patel Memorial Hospital in Shirpur

HOSMAC spearheads north Maharashtra’s project management for Tapanbhai Patel Memorial Hospital in Shirpur: Our Bureau, Bengaluru Tuesday, May 5, 2026, 14:30 Hrs [IST] HOSMAC, As ...
Pharmabiz

Lupin receives US FDA approval for glycerol phenylbutyrate oral liquid

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Applications for glycerol ...
Pharmabiz

Evotec nominates first preclinical development candidate in dermatology collaboration with Almirall

Evotec SE, a life science company that is pioneering the future of drug discovery and development, announced the nomination of a small molecule preclinical development candidate (PDC) from its ...
Pharmabiz

AiMeD welcomes UP Govt's integrated medical research application system

AiMeD welcomes UP Govt's integrated medical research application system: Our Bureau, New Delhi Tuesday, May 5, 2026, 13:45 ...
Pharmabiz

Neurocrine Biosciences initiates phase 1 study of NBIP-'2118, a corticotropin-releasing factor type 2 receptor agonist to treat obesity

Neurocrine Biosciences initiates phase 1 study of NBIP-'2118, a corticotropin-releasing factor type 2 receptor agonist to treat obesity: San Diego Tuesday, May 5, 2026, 10:00 Hrs ...